Translational medicine brings new diagnostic and prognostic biomarkers, as well as devices and therapeutics, to positively impact the lives of people at risk of cancer as well as patients with cancer. Translational research disease groups (TRDGs) coordinate assessment of research opportunities, particularly through investigator-initiated trials, interdisciplinary collaboration, research support, and trainee involvement.

Fox Chase has a rich tradition in training the next generation of scientists, and believes that training the next generation of cancer scientists and physicians is a primary objective of the Center. 

We offer postdoctoral training and  programs and internships for graduate students and undergraduates, and programs for high school students interested in careers in science and medicine.

Fox Chase R&D Alliances promote collaborative pre-clinical and clinical research relationships between corporate sponsors and Fox Chase’s academic investigators, high-level strategic partnerships with industry when appropriate, and assist health care partners through Fox Chase International as they pursue opportunities in areas such as healthcare professional traiing, healthcare growth initiatives, and patient care.